| Intrinsic Valuation of: ASTS | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | -2 | Market Cap | $32B | |||||
| 2021 | - | - (-) | P/E Ratio | - | Total Asset | $5B | |||||
| 2022 | $-214M | - (-) | Net Income | $-342M | Total Debt | $2B | |||||
| 2023 | $-268M | -25.3% (-%) | EBITDA | $-370M | Total Liab | $3B | |||||
| 2024 | $-300M | -12.1% (-%) | Opr Margin | -405.70 | Debt/Equity | 0.92 | |||||
| 2025 | $-1B | -297.2% (75.3%) | PreTax Margin | -456.56 | BV/Share | 5 | |||||
| 5Y Average FCF | $-494M | 2.5% (-%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 13.75% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (2.5%) | ||||||||||
| 2026 | $0 | MBG Intrinsic Value | $-16 | ||||||||
| 2027 | $0 | ||||||||||
| 2028 | $0 | ||||||||||
| 2029 | $0 | ||||||||||
| 2030 | $0 | ||||||||||
| 2031 | $0 | ||||||||||
| Terminal Value | $0 | Net Worth/Share | $8 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $0 | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $2B | $0 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $2B | WACC | 11.8% | 0 | 0 | 0 | 0 | 0 | |||
| Equity Value | $128M | 12.3% | 0 | 0 | 0 | 0 | 0 | ||||
| Shares Outstanding | 298,746,383 | 12.9% | 0 | 0 | 0 | 0 | 0 | ||||
| 13.4% | 0 | 0 | 0 | 0 | 0 | ||||||
| DCF Intrinsic Value | $0 | 14.0% | 0 | 0 | 0 | 0 | 0 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||